Buchalter Launches FDA Regulatory Compliance Group
March 7, 2025. Buchalter is pleased to announce the launch of its FDA Regulatory Compliance Group, dedicated to guiding clients through the complex regulatory landscape of the U.S. Food and Drug Administration (FDA) and related agencies. This new practice group provides strategic counsel, from inception to marketing, compliance, and litigation defense. Buchalter’s launch of the FDA […]
Buchalter Launches FDA Regulatory Compliance Group Read More »